FDA Inspection 1007284 — Piedmont Athens Regional Medical Ctr
The FDA completed an inspection of Piedmont Athens Regional Medical Ctr on April 6, 2017 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Athens, GA (United States)